Literature DB >> 9735138

Therapeutic alternatives in metastatic neuroendocrine tumors.

C A Miller1, E C Ellison.   

Abstract

In the treatment of neuroendocrine tumors that cannot be resected for cure two goals must be addressed: (1) the control of symptoms related to hormonal hypersecretion and (2) the prolongation of survival by destruction of tumor of the limitation of its growth. Clinical approaches, medical and surgical, have been developed in recent years to meet these goals. Surgical options in the face of metastatic disease include resection of hepatic metastases, cryoablation, and liver transplantation. Medical therapy includes treatment of symptomatic hypersecretory states and systemic chemotherapeutic and immunomodulatory regimes. Hepatic artery chemoembolization has also been used successfully in the treatment of hepatic metastases of neuroendocrine tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735138

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  9 in total

Review 1.  Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.

Authors:  Wojciech C Blonski; K Rajender Reddy; Abraham Shaked; Evan Siegelman; David C Metz
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Synergistic effect of pasireotide and teriflunomide in carcinoids in vitro.

Authors:  Yash Somnay; Herbert Chen; Muthusamy Kunnimalaiyaan
Journal:  Neuroendocrinology       Date:  2012-09-04       Impact factor: 4.914

Review 3.  Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.

Authors:  Scott N Pinchot; Susan C Pitt; Rebecca S Sippel; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Curr Opin Investig Drugs       Date:  2008-06

4.  Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.

Authors:  Susan C Pitt; Herbert Chen; Muthusamy Kunnimalaiyaan
Journal:  Ann Surg Oncol       Date:  2009-07-09       Impact factor: 5.344

5.  Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.

Authors:  Guojun Chen; Renata Jaskula-Sztul; Corinne R Esquibel; Irene Lou; Qifeng Zheng; Ajitha Dammalapati; April Harrison; Kevin W Eliceiri; Weiping Tang; Herbert Chen; Shaoqin Gong
Journal:  Adv Funct Mater       Date:  2017-01-17       Impact factor: 18.808

Review 6.  [Radiofrequency ablation of liver metastases].

Authors:  P L Pereira; S Clasen; A Boss; D Schmidt; C Gouttefangeas; C Burkart; J Wiskirchen; G Tepe; C D Claussen
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

7.  Survival and functional quality of life after resection for hepatic carcinoid metastasis.

Authors:  Clayton D Knox; Irene D Feurer; Paul E Wise; Laura W Lamps; J Kelly Wright; Ravi S Chari; D Lee Gorden; C Wright Pinson
Journal:  J Gastrointest Surg       Date:  2004 Sep-Oct       Impact factor: 3.267

8.  Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment.

Authors:  Yingnan Si; JiaShiung Guan; Yuanxin Xu; Kai Chen; Seulhee Kim; Lufang Zhou; Renata Jaskula-Sztul; X Margaret Liu
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 9.  Actual role of radiofrequency ablation of liver metastases.

Authors:  Philippe L Pereira
Journal:  Eur Radiol       Date:  2007-02-15       Impact factor: 7.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.